Latest filings (excl ownership)
15-12B
Securities registration termination
11 Oct 16
25-NSE
Exchange delisting
28 Sep 16
8-K
Termination of a Material Definitive Agreement
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Sep 16
SC 14D9/A
Tender offer solicitation (amended)
28 Sep 16
SC TO-T/A
Third party tender offer statement (amended)
28 Sep 16
SC 14D9/A
Tender offer solicitation (amended)
23 Sep 16
SC TO-T/A
Third party tender offer statement (amended)
23 Sep 16
SC 14D9/A
Tender offer solicitation (amended)
14 Sep 16
SC TO-T/A
Third party tender offer statement (amended)
14 Sep 16
SC 14D9/A
Tender offer solicitation (amended)
13 Sep 16
SC 14D9/A
Tender offer solicitation (amended)
9 Sep 16
SC TO-T/A
Third party tender offer statement (amended)
9 Sep 16
8-K
Departure of Directors or Certain Officers
2 Sep 16
SC 14D9
Tender offer solicitation
30 Aug 16
SC TO-T
Third party tender offer statement
30 Aug 16
SC14D9C
Written communication relating to third party tender offer
29 Aug 16
SC14D9C
Written communication relating to third party tender offer
25 Aug 16
SC TO-C
Information about tender offer
23 Aug 16
8-K
Pfizer to Acquire Medivation
22 Aug 16
SC TO-C
Information about tender offer
22 Aug 16
SC TO-C
Information about tender offer
22 Aug 16
SC14D9C
Written communication relating to third party tender offer
22 Aug 16
10-Q
2016 Q2
Quarterly report
9 Aug 16
8-K
Medivation Reports Second Quarter 2016 Financial Results
9 Aug 16
S-8
Registration of securities for employees
9 Aug 16
8-K
Regulation FD Disclosure
29 Jul 16
8-K
Regulation FD Disclosure
6 Jul 16
8-K
Medivation Enters into Confidentiality Agreements, Including with Sanofi
5 Jul 16
DFAN14A
Additional proxy materials by non-management
5 Jul 16
8-K
Departure of Directors or Certain Officers
27 Jun 16
8-K
Medivation Sends Letter to Stockholders to Set the Record Straight on Sanofi’s Misleading Claims
24 Jun 16
8-K
Other Events
24 Jun 16
CT ORDER
Confidential treatment order
24 Jun 16
Latest ownership filings
4
W ANTHONY VERNON
30 Sep 16
4
Tseli Lily Yang
30 Sep 16
4
Jennifer Jarrett
30 Sep 16
4
Michael L King
30 Sep 16
4
Andrew Kenneth William Powell
30 Sep 16
4
Marion McCourt
30 Sep 16
4
KATHRYN E FALBERG
30 Sep 16
4
WENDY L YARNO
30 Sep 16
4
David Hung
30 Sep 16
4
Dawn Svoronos
30 Sep 16
4
KIM D BLICKENSTAFF
30 Sep 16
4
Patrick Machado
30 Sep 16
4
Mohammad Hirmand
30 Sep 16
4
KIM D BLICKENSTAFF
26 Sep 16
4/A
David Hung
19 Sep 16
4
Mohammad Hirmand
19 Sep 16
4
David Hung
19 Sep 16
SC 13G/A
Medivation, Inc.
12 Sep 16
SC 13G/A
Medivation, Inc.
11 Jul 16
4
KATHRYN E FALBERG
23 Jun 16
4
Dawn Svoronos
23 Jun 16
4
Michael L King
23 Jun 16
4
WENDY L YARNO
23 Jun 16
4
KIM D BLICKENSTAFF
23 Jun 16
4
W ANTHONY VERNON
23 Jun 16
4
Clarence Patrick Machado
23 Jun 16
4
Andrew Kenneth William Powell
6 Jun 16
4
Rick Bierly
9 May 16
3
Jennifer Jarrett
8 Apr 16
4
Jennifer Jarrett
8 Apr 16
4
Mohammad Hirmand
8 Apr 16
4/A
Andrew Kenneth William Powell
22 Mar 16
4
Dawn Svoronos
16 Mar 16
4
Mohammad Hirmand
7 Mar 16
4
David Hung
7 Mar 16
4
Rick Bierly
7 Mar 16
4
David Hung
2 Mar 16
4
Mohammad Hirmand
2 Mar 16
4
Tseli Lily Yang
2 Mar 16
4
Rick Bierly
2 Mar 16